Selena Yu, Senior Medical Analyst, GlobalData explains, Rising global rates of obesity and type II diabetes, coupled with growing public awareness of GLP 1R agonists, are fueling expansion in the weight loss drug market
Rising Awareness of Obesity Management:With obesity rates climbing, affecting around30% of the adult populationin the Philippines, there is a heightened focus on effective weight management solutions
During the trial, additional anti-diabetic medication was initiated as an add on to randomized treatment by 1.9% and 1.2% of patients randomized to RYBELSUS 14 mg and empagliflozin 25 mg, respectively
On MyFoodAllergyTeam, more than 41,000 members come together to ask questions, give advice, and share their stories with others who understand life with food allergies
Together with InnoSlim and powerful thermogenic ingredients, Inno Shred GLP-1 turns your body into a fat-burning machine, promoting a leaner, more toned physique